- Home
- AWH vs CING Comparison
AWH vs CING Comparison
Compare AWH & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWH
- CING
- Stock Information
- Founded
- AWH 1993
- CING 2012
- Country
- AWH United States
- CING United States
- Employees
- AWH N/A
- CING N/A
- Industry
- AWH Medical/Dental Instruments
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- AWH Health Care
- CING Health Care
- Exchange
- AWH Nasdaq
- CING Nasdaq
- Market Cap
- AWH 11.7M
- CING 13.5M
- IPO Year
- AWH N/A
- CING 2021
- Fundamental
- Price
- AWH $0.81
- CING $4.10
- Analyst Decision
- AWH Buy
- CING Strong Buy
- Analyst Count
- AWH 2
- CING 3
- Target Price
- AWH $4.40
- CING $96.00
- AVG Volume (30 Days)
- AWH 76.2K
- CING 91.3K
- Earning Date
- AWH 11-14-2024
- CING 11-07-2024
- Dividend Yield
- AWH N/A
- CING N/A
- EPS Growth
- AWH N/A
- CING N/A
- EPS
- AWH N/A
- CING N/A
- Revenue
- AWH $8,963,000.00
- CING N/A
- Revenue This Year
- AWH $11.87
- CING N/A
- Revenue Next Year
- AWH $79.10
- CING N/A
- P/E Ratio
- AWH N/A
- CING N/A
- Revenue Growth
- AWH N/A
- CING N/A
- 52 Week Low
- AWH $0.67
- CING $1.80
- 52 Week High
- AWH $5.65
- CING $152.40
- Technical
- Relative Strength Index (RSI)
- AWH 50.69
- CING 41.97
- Support Level
- AWH $0.68
- CING $4.09
- Resistance Level
- AWH $0.90
- CING $4.39
- Average True Range (ATR)
- AWH 0.07
- CING 0.20
- MACD
- AWH 0.00
- CING -0.02
- Stochastic Oscillator
- AWH 49.09
- CING 0.22
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.